EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 20-Oct-2026 03:16 ET (20-Oct-2026 07:16 GMT/UTC)

New statewide plan aims to eliminate cervical cancer in Texas by 2032

University of Texas M. D. Anderson Cancer Center
Business Announcement

A statewide coalition of Texas health systems, academic institutions, community organizations and advocates today announced the Texas Lone Star Cervical Cancer Elimination Plan 2027-2032, a five-year roadmap to eliminate cervical cancer in Texas.

Of mice and zebrafish: how MSK scientists solved a decades-old mystery and uncovered new insights about inflammation

Memorial Sloan Kettering Cancer Center
Peer-Reviewed Publication

A team of researchers from Memorial Sloan Kettering Cancer Center has solved a decades-old scientific puzzle and revealed that a critical inflammatory signaling pathway doesn’t just summon immune cells to the place where they’re needed — it also protects healthy cells from being damaged by the immune response

Journal: Nature

Ochsner Baton Rouge expands breast cancer screening hours throughout October

Ochsner Health System
Business Announcement

Massages & Mammos is designed to make taking care of breast health a little easier and more comfortable. Women can schedule their annual mammogram while enjoying complimentary chair massages, light refreshments and opportunities to speak directly with Ochsner breast health experts.

LSU Health New Orleans recruits internationally recognized leader to establish institution’s first academic department of radiation oncology

Louisiana State University Health Sciences Center
Business Announcement

LSU Health New Orleans has recruited internationally recognized radiation oncologist and physician-scientist Puneeth Iyengar, M.D., Ph.D., to establish and lead the medical school’s first academic Department of Radiation Oncology.

Key driver of aggressive prostate cancer identified, suggesting new way to reverse drug resistance

Fred Hutchinson Cancer Center
Peer-Reviewed Publication

Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more aggressive, drug-resistant form of the disease.

Journal: Nature
Funder: National Institutes of Health, American Cancer Society

New device targets nerve signals to treat cancer-related wasting, moving to first human trial

Terasaki Institute for Biomedical Innovation
Business Announcement

Los Angeles, CA – October 07, 2026 - The Terasaki Institute for Biomedical Innovation announced today that OnVagus, a medical device company incubating at the Institute, has received institutional and regulatory approval to begin the first human trial of its noninvasive nerve-stimulation device for patients experiencing cancer-related wasting.

Funder: American Cancer Society, BrightEdge Entrepreneurs Program (BEE), National Cancer Institute (NCI) SBIR program

Researchers identify aggressive molecular features in low-risk prostate cancer

KTH, Royal Institute of Technology
Peer-Reviewed Publication

A new study revealed molecular features linked to more aggressive prostate cancer in a subset of patients who had been classified as low risk, highlighting biological differences that may not be apparent from clinical measures alone. The results could lead to new therapeutic strategies.

Journal: npj Digital Medicine

What’s next for theranostics?

Society of Nuclear Medicine and Molecular Imaging
Peer-Reviewed Publication

Theranostics is now a mature cancer treatment modality, and The Journal of Nuclear Medicine (JNM) is capturing the moment in a new supplement: “Theranostics: The State of the Art.” Guest edited by Ken Herrmann, MD, MBA, with JNM Editor-in-Chief Johannes Czernin, MD, the supplement brings together top voices in the field to map out where theranostics stands today and where it’s headed next.

Journal: Journal of Nuclear Medicine

Gene expression linked to survival differs by kidney cancer subtype

Tokyo University of Science
Peer-Reviewed Publication

A gene involved in cell signaling and lipid metabolism, CTDNEP1, is associated with poorer survival in clear cell renal cell carcinoma (ccRCC), a study from Tokyo University of Science and Nippon Medical School has found. Researchers analyzed publicly available cancer databases to examine CTDNEP1 expression in ccRCC and papillary RCC. They found that higher CTDNEP1 expression was associated with poorer survival in ccRCC, suggesting its potential as a candidate prognostic biomarker for this subtype.

Journal: Anticancer Research

Novel radiotherapy may save increasingly many rectal cancer patients from surgery and stoma

Tampere University
Reports and Proceedings

Tampere University Hospital (Tays) has begun to offer a new radiotherapy to treat rectal cancer in which an intensive dose of radiation is targeted to the tumour surface. The aim is to destroy the tumour so that increasingly many patients may avoid a massive surgery and a potentially permanent stoma. Finland is at the forefront of implementing this novel treatment.

11
12
13
14
15